Drugs Market Research Reports & Industry Analysis

... United States Off–Label Drugs market. This 67 page report with 16 Figures and 1 Table studies 6 Off–Label Drugs Segment. The 6 Off–Label Drugs Segment Covered in the Report are as Follows: 1. Cancer Off–Label Drugs 2. Central Nervous System (CNS) Off–Label Drugs 3. Anti–Ashmatics Off–Label Drugs 4. Anti ...

... , namely, adverse event reporting software, drug safety audits software, issue tracking software, and fully integrated software. The global pharmacovigilance and drug safety software market is segmented into two segments ... : Comprehensive information on pharmacovigilance and drug safety software offered by the top 10 players in the pharmacovigilance and drug safety software market. The report analyzes the pharmacovigilance and drug safety software market on the basis ...

... 2013 and 2014: Supply situation has been playing a dominant role in the performance of China's vitamin industry since 2013, ... trend of China's vitamin industry. What to report: An overview of China's vitamin production, 2011-2013; Price changes of China's vitamins, 2011-Sept. 2014; Dynamics of leading vitamin ...

... per-capita income, and strong research & development investments, the pharmaceutical market in the US has witnessed an upward surge over the past few ... are holding back growth in the Generics industry. According to RNCOS “US Generic Drug Market Outlook 2018”, the US Generics market, which was US$ 43.5 Billion ...

... of report: In this report, CCM has analyzed price of feed-grade vitamins in 2014. What to report: In this report, China's feed-grade vitamin prices in 2014 have been analyzed exhaustively from ...

... clinical significance and market needs for major current and emerging NAT assays, as well as extensive listings of companies developing and marketing ... . This report also presents strategic assessments of current and emerging suppliers of nucleic acid testing products, including their sales, product portfolios ...

... , biochips, genosensors, microarrays, labs-on-the-chip, and other.The report also presents strategic assessments of current and emerging suppliers of nucleic acid testing products, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative ...

... is already available on the market, e.g., DNA extractors, DNA synthesizers, thermal cyclers, robotic work-stations, and automated DNA probe analysis systems. The report reviews current instrumentation technologies, and compares features of leading molecular diagnostics analyzers marketed by Abbott, Beckman ...

... for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others."Drugs of Abuse Testing Market: US, Europe, Japan" is a unique study designed to help current suppliers and potential market entrants identify and evaluate emerging ...

... , as well as test volume and sales forecasts by country. The report also presents strategic profiles of current and emerging suppliers of nucleic acid testing products in terms of their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and ...

This report provides: Estimates of facilities performing DNA sequencing and molecular diagnostic testing in France, Germany, Italy, Japan, Spain, UK and USA. Five-year test volume and sales forecasts by country.

... a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others."Therapeutic Dry Monitoring: US, Europe, Japan" is a unique worldwide market and technology assessment designed to help current suppliers and potential market entrants ...

... Competitor Analysis: Alpha Synuclein and LRRK2 Inhibitors - Novel Drug Candidates for Parkinson's Disease The Competitive Intelligence report about Alpha ... on inhibitors of the molecular targets alpha-synuclein and LRRK2 including small molecules, antibodies, vaccines and RNAi. Competitor projects are listed ...

Traditionally Innovation and drug discovery had taken a back seat in the Indian pharma industry with a few blips here and there. ... 2-3 years thereby rewarding their investors. . In this Outlook we have initiated coverage on Connexios, Bugworks, Cellworks, Tergene and hope that soon we will be able to expand ...

... CCM has analyzed hot spots in China's vitamin industry in 2014. What to report: In this report, hot spots in China's vitamin industry in 2014 ... have been analyzed exhaustively from the following aspects: Background; Company dynamics; Market prices change of vitamins ...

... cases and 35,600 cases respectively. Liver disease drug market competition of our country is really fierce. China’s liver disease drug market can be divided ... data issued by China Competition Information shows that, the scale of China liver disease drug market is close to RMB 43 billion in 2013. China has become the ...

... most likely that the EU Regulation for Orphan medicinal products would have a significant impact in the coming years. “Europe Orphan Drug Market & Clinical ... Orphan Drug Status Comprehensive Insight on Orphan Drug Clinical Pipeline Europe Orphan Drug Clinical Pipeline: 326 Drugs Majority Orphan Designated ...

... The higher sales will depend upon efficacy of newly developed intramuscular drug and marketing strategy to drive its sales. They are used ... supposed to be cost effective along with pharmacologically efficient and minimized side effects. “Intramuscular Drug Delivery Market & Pipeline Insight” Report Findings: ...

... life threatening effects. Also, every year large number of protein based drugs are introduced in market for the treatment of various ailments. ... innovative products with higher therapeutic capabilities will enter in market in coming years. “Subcutaneous Drug Delivery Market & Pipeline Insight” Report Findings ...

... by the introduction of cheaper products made available by local manufacturers. Some key market players of antidiabetics include Sanofi Aventis, Takeda Pharmaceuticals ... Research has segmented the global antidiabetics market on the basis of product and region: Global Insulin Product Outlook (Revenue, USD Million ...

This report analyzes the worldwide markets for Calcium Carbonate in Metric Tons by the following Product Segments: Ground Calcium Carbonate, and Precipitated Calcium ... 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and ...

This report analyzes the worldwide markets for Vitamins in US$ ThousandS by the following Product types - Vitamin A, Vitamin B Complex, Vitamin C, Vitamin D, Vitamin E, and Vitamin K. Specific End-Use Segments also ... 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary ...

FirstWord’s Trends and Innovations in Drug Pricing report dissects international trends and examines how long-standing dynamics in competitive pricing and ... research and expert interviews, Trends and Innovations in Drug Pricing is an open window to the future of drug pricing. Worldwide, the trend towards payers determining price has ...

... quotation of cholesterol and vitamin D3 (VD3). Garden Biochemical, one of the largest manufacturers of VD3 in the world, the supply of VD3 was in short, ... and project basic information, suggestion or prospect analysis. What to report: In this report, some of the most relevant domestic vitamin projects have ...

... in various ways. In this report, development situation of vitamin listed companies has been described in detail, including company profile, financial performance, product mix, market share ...

... also Physician Views: What opportunity for biosimilar basal insulin?), we are polling US and EU5-based endocrinologists to gauge their assessment of new long-acting insulins ... Lantus sales will be flat next year (due most likely to greater rebating with payers) and the potential leverage their availability will ...

... a direct analyse of China's vitamin trade flows around the volume, price, partners, and an indirect description of industry changes. What to report: In this report, import and export of China's vitamins in 2013 and ...

... Hepatitis C Pipeline Drugs - Clinical Trials The report gives an insight on the Hepatitis C Deals and Acquisitions (2004 - 2014) iGATE RESEARCH report entitled Worldwide - Hepatitis C Drugs Market and Pipeline Drugs Analysis to 2019 provides an in-depth analysis of the drugs, pipeline drugs and the key players ...

... drugs would meet orphan drug criteria. Orphan Drugs are part of the clinical landscape and all stakeholders have valid interests which have to be addressed now. Orphan Drug Market Access: Payer Insights on the Present and Future offers insights from US and European healthcare payers and includes illustrative case ...

... field of pharmaceutical research is being provided considerable impetus through the combination of imaging and screening. Worldwide market for drug discovery technologies explored in this study includes Bioanalytical Assays, Bioinformatics, Cell Based Assays, Genomic Technologies, High Throughput Screening, ...

... disorders, which are extremely life-threatening. As per the official definition, rare diseases are classified as those that affect fewer than 200, ... & FDA Regulatory Framework US Orphan Drug Pipeline by Phase, Indication & Company Marketed Orphan Drug Clinical Insight US Orphan Drug Clinical Pipeline: 570 ...

... purchasing Hard Copy License depending on the location. The Central Nervous System (CNS) disorders market in US is one of the largest segments of pharmaceuticals industry ... with launch of novel drugs will drive the growth of CNS disease market in future. “US CNS Disorders Drug Pipeline Insight 2014” Report ...

... Global HIV Infection Drug Market & Pipeline Insight” Report Highlight: Global HIV Infection Drug Market Overview & Incidence Scenario FDA & EMA Regulation for Development of HIV Drug Global HIV Infection Drug Clinical Pipeline by Phase, Company & Country Global HIV Clinical Pipeline: 315 Drugs ...

... segmented the CIS Insulin market on the basis of product, application, source and region: CIS Insulin Product Outlook Rapid Acting Long Acting Premixed Premixed Analog Short Acting Intermediate Acting CIS Insulin Application ...

... are also being analyzed. A majority of these studies were previously focusing on cervical cells in women. But in recent years, the realm of research has ... lead to the growth of abnormal cells, thus controlling the incidence of cervical cancer. “Cervical Cancer Drug Market & Pipeline Insight” Report Highlights ...

... offers much potential for future prevention and cure over the next two decades. “Schizophrenia Drug Market & Pipeline Insight” Report Highlights: Schizophrenia Drug Market Overview Marketed Drug Profiles & Patent Analysis Clinical Trial Insight by Phase & Country Drug in Clinical Development Phase: ...

... in terms of revenue, accounting for 38.0% share of Latin American demand, followed by Mexico and Argentina. Brazil insulin demand is estimated to grow at a fastest CAGR ... Outlook Human Recombinant Analogs Insulin Regional Outlook Brazil Argentina Chile Mexico Colombia Venezuela Peru Rest of Latin America

... titled “Global Anti-Migraine Drugs Market: Trends and Opportunities (2014-2019)” provides an insight into migraine drugs with a special focus on Triptans. The report also includes the market value ... generic migraine drugs over the next several years will steadily increase diagnosis and drug-treatment rates, leading to sustained annual global growth of anti-migraine drugs market. Other ...

... the function and regulation of iron.The key factors driving growth of the global IV iron industry include escalating number of dialysis ... report analyzes the global iron products industry along with an extensive coverage of global and the US IV iron market. The global IV iron market witnesses intense ...

... top two consumers of feed water-soluble vitamins and minerals in the world, having collectively accounted for more than 61% and 53% of the consumption of feed water-soluble minerals and feed water-soluble vitamins, respectively, in 2012. Asia-Pacific is estimated to be the fastest-growing market for feed water-soluble minerals, in terms of value. Growth is particularly ...

... the diagnostic techniques as the researchers would get a deeper understanding of the disease. Thus, overall, there is significant amount of research currently underway for ... , it is most likely that this market would offer better solutions for the patients. “Crohn’s Disease Drug Market and Pipeline Analysis” ...

... as a result of continued initiatives to improve healthcare access. The Asia Pacific insulin market is oligopolistic in nature and is dominated by three key ... Insulin Regional Outlook India China Australia New Zealand South Korea Taiwan Philippines Vietnam Indonesia Japan Malaysia Thailand Rest of Asia Pacific

... insulin products by exhibiting higher efficacy. North America was the largest regional market ... insulin market on the basis of product, segment (on the basis of source), application and region: Insulin Product Outlook Fast Acting Insulin Short Acting Insulin Intermediate Acting Insulin Long Acting Insulin ...

... is forecasted to grow at a CAGR of over 10% during 2012-2018. Our RNCOS research report, “Global Insulin Market Outlook 2018”, has revealed that the ... comprehensive research work also studies how patent expiry of block buster insulin products would create opportunities for biosimilars. The report conducts an ...

... Produced by Different Enterprises in China Hospital Market Sales Value of Valsartan Hydrochlorothiazide in China Hospital Market Major Valsartan Hydrochlorothiazide Manufacturers in China Prospect of China Valsartan Hydrochlorothiazide Market The following enterprises and people are recommended to ...

... of Adalimumab in Hospital Market in China Price of Adalimumab Produced by Vetter Pharma Fertigung GmbH & Co. KG in China Hospital, 2014 Manufacturing Schedule of Adalimumab Generic Drug Prospect of China Adalimumab Market The following enterprises and people are recommended to purchase this report: ...

... China. According to CRI's market investigation, the sales revenue of Lyrica in Chinese sample hospital market grew over 100 times from 2010 to 2013. ... incidence of epilepsy is doomed to increase, which leads to a bright future for pregabalin market in China. Through this report, the readers can acquire the ...

... by kidney and liver that stimulates erythropoiesis. Indications of EOP approved in China are renal anemia, anemia after chemotherapy and surgery perioperative ... space for EPO used in anemia after chemotherapy in China. Originally developed by Amgen Inc., epoetin alfa was approved to the U.S. in June 1989 by ...

... approved to China in 2002 to treat CML and GIST. Its market size keeps increasing after its launch. According to CRI's investigation on sample ... Hospital Market Incidence of CML in China Manufacturing Schedule of Imatinib Generic Drug Prospect of China Imatinib Market The following enterprises and people ...

... the end of 2013 there have been over 10 million schizophrenia patients in China, and the number is still increasing year after year. Schizophrenia ... in Different Dosage Forms in China Hospital Market Prospect of China Aripiprazole Market The following enterprises and people are recommended to purchase this ...